{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-098335","form_type":"8-K","ticker":"LIMN","cik":"0001971387","company_name":"Liminatus Pharma, Inc.","filed_at":"2026-08-18T20:06:04+00:00","discovered_at":"2026-08-18T20:07:00.406730+00:00","generated_at":"2026-08-18T20:07:08.649192+00:00","sec_items":["3.01","3.03","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Liminatus Pharma announces 1-for-50 reverse stock split to regain Nasdaq bid price compliance","bullets":["Board approved 1-for-50 reverse stock split; effective at close of trading Aug 20, 2026; split-adjusted trading on Nasdaq Capital Market Aug 21, 2026 under LIMN.","Outstanding shares would drop from 67,160,362 to ~1,343,208 (as of July 2, 2026); fractional shares rounded up; CUSIP changes to 53271X 207.","Nasdaq Panel granted transfer to Capital Market effective Aug 4, 2026; must show $1.00 closing bid for 10 consecutive days by Sept 3, 2026 to regain compliance.","Company had been non-compliant with MVLS, MVPHS, and bid price rules; regained compliance with stockholders' equity and MVPHS requirements."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-098335","json":"https://secwatch.observer/filing/0001104659-26-098335.json","markdown":"https://secwatch.observer/filing/0001104659-26-098335.md","text":"https://secwatch.observer/filing/0001104659-26-098335.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926098335/0001104659-26-098335-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926098335/tm2623497d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-18T20:07:08.649192+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}